摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-(2-fluorobenzyl)piperazin-1-yl)-1H-indole | 753440-05-0

中文名称
——
中文别名
——
英文名称
4-(4-(2-fluorobenzyl)piperazin-1-yl)-1H-indole
英文别名
4-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-1H-indole
4-(4-(2-fluorobenzyl)piperazin-1-yl)-1H-indole化学式
CAS
753440-05-0
化学式
C19H20FN3
mdl
——
分子量
309.386
InChiKey
YJSFQVKXLJBVMK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    22.3
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • 5HT7 receptor ligands and compositions comprising the same
    申请人:Laboratorios Del. Dr. Esteve, S.A.
    公开号:EP2149373A1
    公开(公告)日:2010-02-03
    The present invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, especially as agonists, identified by using a pharmacophore and a descriptor's profile filter as well as to pharmaceutical compositions comprising them. These compounds are useful in therapy in particular for the treatment and or prophylaxis of a disease in which 5-HT7 is involved, such as CNS disorders.
    本发明涉及具有药理活性的化合物,特别是作为5-HT7受体激动剂,通过使用药效团和描述符的配置文件筛选识别,以及包含它们的药物组合物。这些化合物在治疗中特别有用,特别是用于治疗和/或预防涉及5-HT7的疾病,如中枢神经系统紊乱。
  • 5HT7 RECEPTOR LIGANDS AND COMPOSITIONS COMPRISING THE SAME
    申请人:Pascual-Ramon Rosalia
    公开号:US20110183991A1
    公开(公告)日:2011-07-28
    The present invention relates to compounds having pharmacological activity towards the 5-HT 7 receptor, especially as agonists, identified by using a pharmacophore and a descriptor's profile filter as well as to pharmaceutical compositions comprising them. These compounds are useful in therapy in particular for the treatment and or prophylaxis of a disease in which 5-HT 7 is involved, such as CNS disorders.
  • [EN] 5HT7 RECEPTOR LIGANDS AND COMPOSITIONS COMPRISING THE SAME<br/>[FR] LIGANDS DU RÉCEPTEUR 5-HT7 ET COMPOSITIONS LES CONTENANT
    申请人:ESTEVE LABOR DR
    公开号:WO2010012817A2
    公开(公告)日:2010-02-04
    The present invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, especially as agonists, identified by using a pharmacophore and a descriptor's profile filter as well as to pharmaceutical compositions comprising them. These compounds are useful in therapy in particular for the treatment and or prophylaxis of a disease in which 5-HT7 is involved, such as CNS disorders.
查看更多